» Articles » PMID: 2550538

Effects of Neuropeptide Y on the Renal, Mesenteric and Hindlimb Vascular Beds of the Conscious Rabbit

Overview
Date 1989 Jul 1
PMID 2550538
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of neuropeptide Y (NPY, 10 micrograms/kg bolus i.v.) on renal, mesenteric and hindlimb blood flow were determined in intact conscious rabbits with chronically implanted Doppler ultrasonic flow transducers. The role of sympathetic neuro-effectors was assessed using inhibition of peripheral alpha-adrenoceptors with phentolamine in each group, and in the renal flow group following chemical sympathectomy with 6-hydroxydopamine. In controls, NPY caused markedly non-uniform peak responses. Renal blood flow fell from 2.16 +/- 0.12 kHz to a minimum of 0.26 +/- 0.07 kHz following NPY administration (P less than 0.05). Mesenteric blood flow was reduced from 2.04 +/- 1.17 to 1.54 +/- 0.11 kHz (P less than 0.05). blood flow increased transiently from 2.33 +/- 0.15 to a peak of 3.33 +/- 0.19 kHz (P less than 0.05). Renal vascular resistance rose by 1189 +/- 309% and mesenteric resistance by 54 +/- 9% (P less than 0.05), while hindlimb resistance fell by 24 +/- 3% (P less than 0.05). Pretreatment with phentolamine accentuated the peak pressor response and the reduction in heart rate induced by NPY administration but had little effect on the local haemodynamic changes in each vascular bed. There was no change in the renal vascular response to NPY following sympathectomy. Indeed, the peak NPY-induced reduction in renal blood flow seen in control animals (87 +/- 4%) was unaffected by either alpha-adrenoceptor inhibition (90 +/- 5%) or by sympathectomy (86 +/- 5%). In conscious rabbits with intact cardiovascular reflexes, pharmacological doses of NPY cause profound renal vasoconstriction with smaller changes in mesenteric and hindlimb flow.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?.

Muskiet M, Smits M, Morsink L, Diamant M Nat Rev Nephrol. 2013; 10(2):88-103.

PMID: 24375052 DOI: 10.1038/nrneph.2013.272.


Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Baltazi M, Katsiki N, Savopoulos C, Iliadis F, Koliakos G, Hatzitolios A Am J Cardiovasc Dis. 2012; 1(1):48-59.

PMID: 22254185 PMC: 3253505.


Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

Bischoff A, Erdbrugger W, Smits J, Michel M J Physiol. 1996; 495 ( Pt 2):525-34.

PMID: 8887762 PMC: 1160810. DOI: 10.1113/jphysiol.1996.sp021612.


Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity.

Dietrich M, Fretschner M, Nobiling R, Persson P, STEINHAUSEN M J Physiol. 1991; 444:303-15.

PMID: 1822552 PMC: 1179934. DOI: 10.1113/jphysiol.1991.sp018879.


Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.

Persson P, Ehmke H, Nafz B, Lang R, HACKENTHAL E, Nobiling R J Physiol. 1991; 444:289-302.

PMID: 1688030 PMC: 1179933. DOI: 10.1113/jphysiol.1991.sp018878.